Literature DB >> 31149053

BIOINFORMATIC ANALYSIS IDENTIFIES POTENTIALLY KEY DIFFERENTIALLY EXPRESSED GENES AND PATHWAYS IN ORBITAL ADIPOSE TISSUES OF PATIENTS WITH THYROID EYE DISEASE.

F F Zhu1, L Z Yang1.   

Abstract

CONTEXT: Thyroid eye disease (TED), an orbital inflammatory status, generally occurred in Graves' disease.
OBJECTIVE: This study aimed to acquire further insight into molecular mechanisms of TED, especially several key involved genes and pathways.
DESIGN: The microarray dataset GSE58331 including expression data for orbital adipose tissue samples, isolated from TED patients and normal controls, was downloaded from a publicly accessible Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified from 23 adipose tissues of TED patients versus 20 samples from normal controls. SUBJECTS AND METHODS: A protein-protein interaction network of DEGs was constructed by using Search Tool for the Retrieval of Interacting Genes and Cytoscape 3.6.0. Several hub genes/proteins were extracted from the protein-protein interaction network based on connectivity degree. Furthermore, we used the iRegulon plugin of Cytoscape3.6.0 to predict the transcription factors (TFs).
RESULTS: A total of 678 DEGs (538 up- and 140 down-regulated genes) were identified in TED patients. Proopiomelanocortin (POMC), interleukin 2 (IL-2), G protein subunit gamma 3 (GNG3), CXC motif chemokine receptor 4 (CXCR4), toll like receptor 4 (TLR4), colony stimulating factor 1 receptor (CSF1R), lysophosphatidic acid receptor 3 (LPAR3), CXC motif chemokine ligand-8 (CXCL8), etc., were considered as the hub genes among the DEGs. There were 6 TFs predicted to be differentially expressed in regulating the DEGs related to TED. A total of 71 DEGs had been reported to be associated with TED in the Comparative Toxicogenomics Database.
CONCLUSIONS: Through this analysis, we have identified plenty of potential biomarkers and pathways which may have an important role in the pathogenesis of TED. However, these findings require verification by more detailed future experimental studies.

Entities:  

Keywords:  Differentialy expressed gene; Orbital adipose tissue; Protein-Protein Interaction; Thyroid eye disease; Transcription factors Pathway

Year:  2019        PMID: 31149053      PMCID: PMC6535319          DOI: 10.4183/aeb.2019.1

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  39 in total

Review 1.  New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy.

Authors:  R A Ajjan; A P Weetman
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

Review 2.  Cytokines, Graves' disease, and thyroid-associated ophthalmopathy.

Authors:  Andrew G Gianoukakis; Nicole Khadavi; Terry J Smith
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

3.  Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.

Authors:  Alessandro Antonelli; Mario Rotondi; Silvia Martina Ferrari; Poupak Fallahi; Paola Romagnani; Stefano Sellari Franceschini; Mario Serio; Ele Ferrannini
Journal:  J Clin Endocrinol Metab       Date:  2005-11-22       Impact factor: 5.958

4.  Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis.

Authors:  Seema Kumar; Alexey Leontovich; Michael J Coenen; Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

Review 5.  Epidemiology of Graves' orbitopathy.

Authors:  Sudeep Putta-Manohar; Petros Perros
Journal:  Pediatr Endocrinol Rev       Date:  2010-03

6.  Toll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males.

Authors:  Wen-Ling Liao; Rong-Hsing Chen; Hui-Ju Lin; Yu-Huei Liu; Wen-Chi Chen; Yuhsin Tsai; Lei Wan; Fuu-Jen Tsai
Journal:  BMC Med Genet       Date:  2010-11-05       Impact factor: 2.103

Review 7.  Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.

Authors:  Terry J Smith; Chieh Chih Tsai; Mei-Ju Shih; Shanli Tsui; Beiling Chen; Rui Han; Vibha Naik; Chris S King; Chris Press; Shweta Kamat; Robert A Goldberg; Richard P Phipps; Raymond S Douglas; Andrew G Gianoukakis
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

8.  Increased generation of fibrocytes in thyroid-associated ophthalmopathy.

Authors:  Raymond S Douglas; Nikoo F Afifiyan; Catherine J Hwang; Kelvin Chong; Uzma Haider; Patrick Richards; Andrew G Gianoukakis; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2009-11-06       Impact factor: 5.958

9.  Association studies of interleukin-8 gene in Graves' disease and Graves' ophthalmopathy.

Authors:  Li-qun Gu; Hui-ying Jia; Yong-ju Zhao; Nan Liu; Shu Wang; Bin Cui; Guang Ning
Journal:  Endocrine       Date:  2009-10-09       Impact factor: 3.633

10.  The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves' ophthalmopathy--support for a role of autoimmunity against calsequestrin as the triggering event.

Authors:  Leon Wescombe; Hooshang Lahooti; Bamini Gopinath; Jack R Wall
Journal:  Clin Endocrinol (Oxf)       Date:  2010-10       Impact factor: 3.478

View more
  1 in total

1.  Construction of the coexpression network involved in the pathogenesis of thyroid eye disease via bioinformatics analysis.

Authors:  Jinxing Hu; Shan Zhou; Weiying Guo
Journal:  Hum Genomics       Date:  2022-09-08       Impact factor: 6.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.